drug · small molecule
PROSCAR
Marketedupdated 3mo ago/ fi-NA-stə-RYDE /
by $OGN Organon & Co.🔗 ChEMBL
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 4Small molecule drug with a maximum clinical stage of Approval (across all indications), with 4 approved and 6 investigational indications.
targets
3-oxo-5-alpha-steroid 4-dehydrogenase 2
all catalysts(41)
approval · 41
Jun 19, 1992
approval
$OGN13.72+0.15%
PROSCAR (FINASTERIDE) — FDA approval
PROSCAR
→
Aug 20, 1992
approval
$OGN13.72+0.15%
PROSCAR (FINASTERIDE) — FDA approval
PROSCAR
→
Dec 22, 1992
approval
$OGN13.72+0.15%
PROSCAR (FINASTERIDE) — FDA approval
PROSCAR
→
Dec 22, 1992
approval
$OGN13.72+0.15%
PROSCAR (FINASTERIDE) — FDA approval
PROSCAR
→
Apr 5, 1993
approval
$OGN13.72+0.15%
PROSCAR (FINASTERIDE) — FDA approval
PROSCAR
→
Sep 1, 1993
approval
$OGN13.72+0.15%
PROSCAR (FINASTERIDE) — FDA approval
PROSCAR
→
Sep 16, 1993
approval
$OGN13.72+0.15%
PROSCAR (FINASTERIDE) — FDA approval
PROSCAR
→
May 18, 1994
approval
$OGN13.72+0.15%
PROSCAR (FINASTERIDE) — FDA approval
PROSCAR
→
May 18, 1994
approval
$OGN13.72+0.15%
PROSCAR (FINASTERIDE) — FDA approval
PROSCAR
→
Dec 30, 1994
approval
$OGN13.72+0.15%
PROSCAR (FINASTERIDE) — FDA approval
PROSCAR
→
Jul 24, 1996
approval
$OGN13.72+0.15%
PROSCAR (FINASTERIDE) — FDA approval
PROSCAR
→
Aug 28, 1996
approval
$OGN13.72+0.15%
PROSCAR (FINASTERIDE) — FDA approval
PROSCAR
→
May 12, 1997
approval
$OGN13.72+0.15%
PROSCAR (FINASTERIDE) — FDA approval
PROSCAR
→
May 16, 1997
approval
$OGN13.72+0.15%
PROSCAR (FINASTERIDE) — FDA approval
PROSCAR
→
Dec 19, 1997
approval
$OGN13.72+0.15%
PROSCAR (FINASTERIDE) — FDA approval
PROSCAR
→
Mar 20, 1998
approval
$OGN13.72+0.15%
PROSCAR (FINASTERIDE) — FDA approval
PROSCAR
→
Mar 20, 1998
approval
$OGN13.72+0.15%
PROSCAR (FINASTERIDE) — FDA approval
PROSCAR
→
Aug 2, 1999
approval
$OGN13.72+0.15%
PROSCAR (FINASTERIDE) — FDA approval
PROSCAR
→
Jan 17, 2001
approval
$OGN13.72+0.15%
PROSCAR (FINASTERIDE) — FDA approval
PROSCAR
→
Jan 30, 2001
approval
$OGN13.72+0.15%
PROSCAR (FINASTERIDE) — FDA approval
PROSCAR
→
Oct 28, 2002
approval
$OGN13.72+0.15%
PROSCAR (FINASTERIDE) — FDA approval
PROSCAR
→
Nov 26, 2002
approval
$OGN13.72+0.15%
PROSCAR (FINASTERIDE) — FDA approval
PROSCAR
→
Jun 26, 2003
approval
$OGN13.72+0.15%
PROSCAR (FINASTERIDE) — FDA approval
PROSCAR
→
Sep 9, 2003
approval
$OGN13.72+0.15%
PROSCAR (FINASTERIDE) — FDA approval
PROSCAR
→
Sep 23, 2003
approval
$OGN13.72+0.15%
PROSCAR (FINASTERIDE) — FDA approval
PROSCAR
→
Apr 12, 2004
approval
$OGN13.72+0.15%
PROSCAR (FINASTERIDE) — FDA approval
PROSCAR
→
Apr 23, 2004
approval
$OGN13.72+0.15%
PROSCAR (FINASTERIDE) — FDA approval
PROSCAR
→
Mar 23, 2010
approval
$OGN13.72+0.15%
PROSCAR (FINASTERIDE) — FDA approval
PROSCAR
→
Oct 4, 2010
approval
$OGN13.72+0.15%
PROSCAR (FINASTERIDE) — FDA approval
PROSCAR
→
Jun 9, 2011
approval
$OGN13.72+0.15%
PROSCAR (FINASTERIDE) — FDA approval
PROSCAR
→
Jun 10, 2011
approval
$OGN13.72+0.15%
PROSCAR (FINASTERIDE) — FDA approval
PROSCAR
→
Apr 11, 2012
approval
$OGN13.72+0.15%
PROSCAR (FINASTERIDE) — FDA approval
PROSCAR
→
Apr 11, 2012
approval
$OGN13.72+0.15%
PROSCAR (FINASTERIDE) — FDA approval
PROSCAR
→
Apr 11, 2012
approval
$OGN13.72+0.15%
PROSCAR (FINASTERIDE) — FDA approval
PROSCAR
→
Jan 16, 2013
approval
$OGN13.72+0.15%
PROSCAR (FINASTERIDE) — FDA approval
PROSCAR
→
Mar 11, 2014
approval
$OGN13.72+0.15%
PROSCAR (FINASTERIDE) — FDA approval
PROSCAR
→
Jul 6, 2015
approval
$OGN13.72+0.15%
PROSCAR (FINASTERIDE) — FDA approval
PROSCAR
→
Apr 13, 2021
approval
$OGN13.72+0.15%
PROSCAR (FINASTERIDE) — FDA approval
PROSCAR
→
Jun 15, 2021
approval
$OGN13.72+0.15%
PROSCAR (FINASTERIDE) — FDA approval
PROSCAR
→
Aug 25, 2021
approval
$OGN13.72+0.15%
PROSCAR (FINASTERIDE) — FDA approval
PROSCAR
→
Mar 18, 2026
approval
$OGN13.72+0.15%
PROSCAR (FINASTERIDE) — FDA approval
PROSCAR
→
Trials studying PROSCAR
- phase2Clinical Trial to Evaluate CG2001 in Chinese Adult Male Participants With Androgenetic Alopecia
- phase1Study to Evaluate the Drug-drug Interaction Between IY001 and IY002 in Healthy Adult Male Subjects.
- phase3Efficacy and Safety of Finlândia Hair Lotion Association on Androgenetic Alopecia
- N/ABenefits of a Cosmetic Anti-hair Loss in Males With Hair Loss
- phase1Finasteride 5 mg Tablets Under Fasting Conditions
- phase1Finasteride 5 mg Tablets, Non-fasting
- phase3A Study of an Investigational Study Drug for Benign Prostatic Hyperplasia (0906-140)
- phase1Fasting Study of Finasteride Tablets 5 mg and Proscar Tablets 5 mg
News(2)
- Veradermics keeps ‘momentum going’ as baldness drug helps women with hair lossThe Phase 2 data exceeded expectations, lifting company shares as high as nearly $130 apiece and building the case for what may be the first pill specifically approved for female pattern hair loss.biopharma_dive · 29d ago
- Veradermics soars on positive data for baldness treatmentThe results could support the first approval in decades for an oral medicine that can treat male pattern baldness, though the therapy will face competition from generics and over-the-counter medica…biopharma_dive · 3mo ago
Data sources
last refreshed 26m ago
Found something off?
comments(0)
5-min edit window · permanent after that